Inventor

CHWALISZ KRZYSZTOF

DE29 patents

⚠️ This page may combine multiple inventors who share the name “CHWALISZ KRZYSZTOF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHWALISZ KRZYSZTOF

SCHERING AG

Methods of and apparatus for activating the muscle cells or nerves of the uterus or cervix

Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors

Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors

Methods of and apparatus for measuring uterine electrical and mechanical activity

6,7-modified 11β-aryl-4-oestrenes

13-alkyl-11beta-phenylgonanes

13-alkyl-11β-phenylgonanes

11β-phenyl-14βH steroids

Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor

14β-H-, 14-and 15-En-11β-aryl-4-oestrenes

11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same

Methods for measuring uterine electrical and mechanical activity

Coadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor induction

Contraception method using competitive progesterone antagonists and novel compounds useful therein

Contraception method using competitive progesterone antagonists and novel compounds useful therein

Contraception method using competitive progesterone antagonists and novel compounds useful therein

Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor

Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor

Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type

D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents

Antigestagens for the inhibition of uterine synthesis of prostaglandin

Use of antigestagens for softening the nonpregnant cervix

Contraception method using competitive progesterone antagonists and novel compounds useful therein

Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors

14,16β-ethano-15β, 16(1)-cyclo-14β-estra-1,3,5(10)-trienes

UNIV TEXAS

Methods for activating the muscle cells or nerves of the uterus or cervix

Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor

Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor

EASTERN VIRGINIA MED SCHOOL

Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception